Your browser doesn't support javascript.
Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis.
Ghosh, Jyotsna; Kant, Sam; Kastner, Isabel Villegas; Geetha, Duvuru.
  • Ghosh J; Division of Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Kant S; Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Kastner IV; Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Geetha D; Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Kidney Int Rep ; 7(3): 651-652, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1729715
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Kidney Int Rep Year: 2022 Document Type: Article Affiliation country: J.ekir.2021.12.010

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Kidney Int Rep Year: 2022 Document Type: Article Affiliation country: J.ekir.2021.12.010